Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis

This study has been completed.
Information provided by:
National Institutes of Health Clinical Center (CC) Identifier:
First received: August 22, 2001
Last updated: March 3, 2008
Last verified: August 2003
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: August 2003
  Estimated Primary Completion Date: No date given